Onyx Biotec Limited IPO Details
The Onyx Biotec Limited IPO is a book build issue with a total issue size of ₹29.34 cr, comprising of fresh issue of 4810000 equity shares. Onyx Biotec Limited IPO opened for subscription on Nov 13, 2024 and closed on Nov 18, 2024. Onyx Biotec Limited IPO is set price band at ₹58 to ₹61 per share, with a lot size of 2000 shares. Minimum investment for Retail investors was ₹244,000.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Nov 19, 2024, and listed on the NSE on Nov 21, 2024.
Mas Services Limited has been appointed as the registrar. are the Book Running Lead Manager for the issue.
Before investing in the Onyx Biotec Limited IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 58 – 61
- Lot Size
- 2000
- Issue Size
- ₹29.34 Cr
- Minimum Investment
- ₹244000 (4000 Shares)
- Listing Date
- 21 November 2024
Current GMP
₹5 (+8.20%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Onyx Biotec Limited
Onyx Biotec Limited, originally incorporated as Onyx Biotec Private Limited in 2005, was converted into a public limited company in 2024, adopting its current name. The company operates in the pharmaceutical industry, specializing in the manufacture and supply of sterile pharmaceutical products, including Sterile Water for Injections, Dry Powder Injections, and Dry Syrup. It also acts as a contract manufacturer for a range of pharmaceutical products for both domestic and international markets.
Core Business and Products:
- Sterile Water for Injections: Onyx Biotec started operations in 2010 with this product and has grown to become a prominent supplier to major pharmaceutical companies in India.
- Dry Powder Injections and Dry Syrups: The company manufactures these products for various pharmaceutical companies and healthcare providers in India and abroad.
- Contract Manufacturing: Onyx provides end-to-end product development and manufacturing solutions, including regulatory filing support for both Indian and global markets.
Manufacturing Facilities: Onyx operates two manufacturing units in Himachal Pradesh:
- Unit I: Located in Ropar, it has a capacity of producing 638,889 units of Sterile Water for Injections per day.
- Unit II: Located in Nalagarh, it has a production capacity of 40,000 units of Dry Powder Injections and 26,667 units of Dry Syrup per day (in a single shift).
Both units are equipped with modern equipment, follow sustainable practices, and are accredited by global regulatory agencies, including WHO-GMP (Good Manufacturing Practices). These facilities undergo regular audits by clients and regulators to ensure adherence to quality standards.
Key Clients: Onyx has established long-term relationships with leading pharmaceutical companies, including:
- Hetero Healthcare Limited
- Mankind Pharma Limited
- Sun Pharmaceutical Industries Limited
- Aristo Pharmaceuticals Private Limited
- Macleods Pharmaceuticals Limited
- Axa Parenterals Limited
- FDC Limited
- Zuventus Healthcare Limited
- Akums Drugs and Pharmaceuticals Limited
- Reliance Life Sciences Limited
Onyx Biotec Limited is a growing player in the pharmaceutical manufacturing sector, known for its high-quality sterile products and strong client relationships. The company is focused on expanding its capabilities through strategic investments in manufacturing upgrades and packaging technology, aiming to strengthen its market position both in India and internationally.
Onyx Biotec Limited IPO Promoters
- Sanjay Jain
- Naresh Kumar
- Fateh Pal Singh
Promoters Holding
Holding Pre Issue
88.60%
Holding Post Issue
0.00%
Onyx Biotec Limited IPO Objective
The Company proposes to utilize the Net Proceeds from the Issue towards the following objects:
- Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use.
- Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections.
- Prepayment or repayment of all or a portion of certain loans availed by the Company.
- General Corporate Purposes.
Address / Contact Info
Onyx Biotec Limited
Bir Plassi Near Sainimajraropar,
Nalagarh Road, District Solan –
174 101, Himachal Pradesh
Phone: +91 172 265 6384
Email: generalinfo@onyxbiotec.com
Website: http://www.onyxbiotec.com
IPO Snapshot
Book Running Lead Managers
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Onyx Biotec Limited IPO is a Book-building IPO with a total issue size of ₹29.34 crore. The Onyx Biotec Limited IPO price band is ₹58 to 61 per share. The Onyx Biotec Limited IPO subscription opens on Wed, Nov 13, 2024, and closes on Mon, Nov 18, 2024. The Onyx Biotec Limited IPO will be listed on the NSE. Mas Services Limited is the registrar for the Onyx Biotec Limited IPO.
The Onyx Biotec Limited IPO opens on Wed, Nov 13, 2024 and closes on Mon, Nov 18, 2024
Onyx Biotec Limited IPO Price Band is ₹58 to 61 per share.
Onyx Biotec Limited IPO lot size is 2000 shares, Retail investors need a minimum investment of ₹244000 based on the upper price band
The minimum investment for Onyx Biotec Limited IPO is ₹244000, based on one lot of 2000 shares at the upper price band of ₹61 per share.
Investors can apply for the Onyx Biotec Limited IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Mon, Nov 18, 2024. The application amount remains blocked until the Onyx Biotec Limited IPO allotment is finalized.
Onyx Biotec Limited IPO issue size is ₹29.34 crores.
Onyx Biotec Limited IPO allotment date is Wed, Jul 1, 2026.
The registrar for Onyx Biotec Limited IPO is Mas Services Limited. Investors can go to Mas Services Limited website to check Onyx Biotec Limited IPO allotment status, refund processing, and other IPO-related information.
The Onyx Biotec Limited IPO GMP (Grey Market Premium) is ₹5 as of Fri, Nov 22, 2024. Based on the upper price band of ₹61 per share, the estimated Onyx Biotec Limited IPO listing price is ₹66, indicating a potential listing gain of approximately 0% over the issue price.